Which steps in androgen receptor signalling does enzalutamide block?

Enzalutamide competitively inhibits androgen binding to androgen receptors, inhibits nuclear translocation of activated receptors, and inhibits activated androgen receptor association with DNA, even with androgen receptor overexpression and in prostate cancer cells resistant to anti-androgens.